{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T08:49:32Z","timestamp":1770281372340,"version":"3.49.0"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"1","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006084","name":"Office of AIDS Research","doi-asserted-by":"publisher","award":["HHSN269201400012C"],"award-info":[{"award-number":["HHSN269201400012C"]}],"id":[{"id":"10.13039\/100006084","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,1]]},"DOI":"10.1093\/infdis\/jix517","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T15:11:27Z","timestamp":1506093087000},"page":"47-50","source":"Crossref","is-referenced-by-count":37,"title":["No Improvement in Hemoglobin A1c Following Hepatitis C Viral Clearance in Patients With and Without HIV"],"prefix":"10.1093","volume":"217","author":[{"given":"Chloe S","family":"Chaudhury","sequence":"first","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Sheehan","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"Chairez","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Akoth","sequence":"additional","affiliation":[{"name":"Institute of Human Virology, Division of Infectious Diseases, University of Maryland, Baltimore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chloe","family":"Gross","sequence":"additional","affiliation":[{"name":"Institute of Human Virology, Division of Infectious Diseases, University of Maryland, Baltimore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Silk","sequence":"additional","affiliation":[{"name":"Institute of Human Virology, Division of Infectious Diseases, University of Maryland, Baltimore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Kattakuzhy","sequence":"additional","affiliation":[{"name":"Institute of Human Virology, Division of Infectious Diseases, University of Maryland, Baltimore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elana","family":"Rosenthal","sequence":"additional","affiliation":[{"name":"Institute of Human Virology, Division of Infectious Diseases, University of Maryland, Baltimore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyam","family":"Kottilil","sequence":"additional","affiliation":[{"name":"Institute of Human Virology, Division of Infectious Diseases, University of Maryland, Baltimore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Masur","sequence":"additional","affiliation":[{"name":"Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colleen","family":"Hadigan","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,11,17]]},"reference":[{"key":"key\n\t\t\t\t20180626074933_CIT0001","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/jvh.12001","article-title":"Sensitive detection of hepatocellular injury in chronic hepatitis C patients with circulating hepatocyte-derived microRNA-122","volume":"20","author":"van der Meer","year":"2013","journal-title":"J Viral Hepat"},{"key":"key\n\t\t\t\t20180626074933_CIT0002","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.jhep.2014.08.003","article-title":"Facts and fictions of HCV and comorbidities: steatosis, diabetes mellitus, and cardiovascular diseases","volume":"61","author":"Negro","year":"2014","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20180626074933_CIT0003","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/jhep.2003.50291","article-title":"Hepatitis C virus infection and incident type 2 diabetes","volume":"38","author":"Mehta","year":"2003","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20180626074933_CIT0004","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1053\/j.gastro.2015.08.035","article-title":"Extrahepatic morbidity and mortality of chronic hepatitis C","volume":"149","author":"Negro","year":"2015","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20180626074933_CIT0005","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10620-015-3907-2","article-title":"Current concepts in diabetes mellitus and chronic liver disease: clinical outcomes, hepatitis C virus association, and therapy","volume":"61","author":"Garc\u00eda-Compe\u00e1n","year":"2016","journal-title":"Dig Dis Sci"},{"key":"key\n\t\t\t\t20180626074933_CIT0006","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.dld.2015.10.016","article-title":"Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality","volume":"48","author":"Vanni","year":"2016","journal-title":"Dig Liver Dis"},{"key":"key\n\t\t\t\t20180626074933_CIT0007","doi-asserted-by":"crossref","first-page":"462.e1","DOI":"10.1016\/j.cmi.2015.12.030","article-title":"Rapid decline of fasting glucose in HCV diabetic patients treated with direct-acting antiviral agents","volume":"22","author":"Pavone","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180626074933_CIT0008","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.cmi.2016.09.021","article-title":"HCV and diabetes: towards a \u2018sustained\u2019 glycaemic improvement after treatment with DAAs","volume":"23","author":"Fabrizio","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180626074933_CIT0009","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/0003-4819-156-4-201202210-00004","article-title":"The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007","volume":"156","author":"Ly","year":"2012","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20180626074933_CIT0010","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2337\/dc17-0485","article-title":"Improvement in glycemic control of type 2 diabetes after successful treatment of hepatitis C virus","volume":"40","author":"Hum","year":"2017","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t20180626074933_CIT0011","article-title":"Improvement of glycemic state among responders to Sofosbuvir\u2014based treatment regimens: Single center experience","author":"Abdel Alem","journal-title":"J Med Virol"},{"key":"key\n\t\t\t\t20180626074933_CIT0012","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/jim-2016-000343","article-title":"Impact of sustained virological response to chronic hepatitic C antiviral therapy on new onset diabetes mellitus type 2 after controlling for metabolic syndrome","volume":"65","author":"Pandya","year":"2017","journal-title":"J Investig Med"},{"key":"key\n\t\t\t\t20180626074933_CIT0013","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1111\/j.1572-0241.2008.02002.x","article-title":"Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study","volume":"103","author":"Giordanino","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t20180626074933_CIT0014","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3390\/v5051292","article-title":"Hepatitis C virus, cholesterol and lipoproteins\u2013impact for the viral life cycle and pathogenesis of liver disease","volume":"5","author":"Felmlee","year":"2013","journal-title":"Viruses"},{"key":"key\n\t\t\t\t20180626074933_CIT0015","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/hep.27424","article-title":"Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1-infected patients","volume":"61","author":"Meissner","year":"2015","journal-title":"Hepatology"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/217\/1\/47\/25089950\/jix517.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T17:39:04Z","timestamp":1570124344000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/217\/1\/47\/4638446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,17]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,11,17]]},"published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jix517","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1,1]]},"published":{"date-parts":[[2017,11,17]]}}}